Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting (BELK@CCP)

Sponsor
Casa di Cura Privata del Policlinico SpA (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04173975
Collaborator
(none)
0
2
8

Study Details

Study Description

Brief Summary

This present study will be devoted to the first clinical study on the efficacy of the BELK system in enhancing mobility and improve the knee rehabilitation process in people with NeuroMuscular Diseases (NMD) and Central Nervous System (CNS) disorders with knee instability that implies deficit in gait and in locomotion during ADL.

Participants will receive a 6-week training program (3 weeks with the BELK orthosis knee module) in a clinical setting in add-on to the standard neuro-rehabilitation treatment. Gait analysis and Instrumental Test will be performed every week till the end of the six-week training period while the Clinical Scales and Questionnaires will be performed after three weeks and at the end of the training period. Finally, additional outcome measures comprise the scores on the System Usability Scale (SUS) to evaluate the hardware and the Software Usability Measurement Inventory (SUMI) to evaluate the software of the BELK orthosis. These two measures will be administrated at the end of training with Belk orthosis, to rate patients' and operators' (e.g., physical therapist, medical doctors) satisfaction.

During 2018, the company GOGOA (www.gogoa.eu), specialized in design, manufacturing and commercialization of Robotic Assisted Rehabilitation (RAR) systems, has developed a first prototype of the BELK system, a powered wearable robotic device that can be used for knee rehabilitation, in the sub-acute phase of knee injuries. As BELK is a wearable device, it can be used both, by the physiotherapist in the rehabilitation centers, improving the knee rehabilitation process and increasing patients' comfort, and accelerating their rehabilitation process.

Casa di Cura del Policlinico (CCP https://www.ccppdezza.it/en/) is a fully integrated multi-specialty clinical center aiming at providing both inpatient and outpatient services mainly directed to neurological patients. The Center is constituted as a Department of Neuro-rehabilitation Sciences, accredited by the Italian National Health System, and economically supported by Regione Lombardia. CCP offers to chronic neurological patients the highest comprehensive standards of care in a comfortable environment, through a multidisciplinary patient management approach organized around a core rehabilitation program.

Condition or Disease Intervention/Treatment Phase
  • Device: With knee exoskeleton
N/A

Detailed Description

The study design comprises a clinical study aimed at assessing efficacy of the BELK orthosis knee module on management of instability of the knee in 15 adults who have NMD or a CNS disorder. Participants will receive a 6-week training program (3 weeks with the BELK orthosis knee module) in a clinical setting in add-on at the standard neurorehabilitation treatment.

The add-on rehabilitation training will be focused on lower limb with specific activities for knee instability, and will comprise 3 weeks using the BELK orthosis knee module and 3 weeks without any orthosis. The activities will concern both physical training (e.g., locomotion task, balance exercise, muscle reinforcement, proprioceptive task) and occupational treatment tasks (e.g., transferring/mobility, meal preparation, house-working).

This clinical study will be a Randomized Control Trial (RCT) crossover longitudinal.

The clinical trial will be split in the following phases :
  • Recruitment. Subjects admitted to CCP Neurorehabilitation unit will be recruited after considering inclusion and exclusion criteria through clinical history and medical visit.

  • Randomization. Enrolled participants will be randomly allocated (per 2 blocked randomization lists, generated electronically by www.random.org) into the BELK assisted group (Group A) or the control group (Group B).

  • Clinical, instrumental and questionnaires assessment at T0 (baseline)

  • Rehabilitation Treatment (first block) three weeks period, all the patients will perform rehabilitation training. The patients allocated in Group A will perform the training wearing the BELK device while patients allocated in Group B will perform the same exercise without any exoskeleton.

  • Clinical, instrumental and questionnaires assessment at T1 (crossover)

  • Rehabilitation Treatment (second block) three weeks period, all the patients will perform rehabilitation training. The patients allocated in Group B will perform the training wearing the BELK device while patients allocated in Group A will perform the same exercise without any exoskeleton.

  • Clinical, instrumental, questionnaires and usability assessment at T2 (final)

  • Additional Instrumental Test will be performed after the first and the second week of each rehabilitation treatment block (i.e., T01, T02, T11, T12).

Instrumental Test consist of:
  • Bio-mechanical performance (gait kinematics/kinetics analysis),

  • Surface electromyography for knee functional evaluation (EMG),

  • 6-minute walking test (6mWT),

  • Baseline assessments uptake (VO2),

  • Hearth rate (HR),

  • Breathing frequency (BF),

  • Timed Up and Go Test (TUG),

  • Stair Climb Test (SCT).

Clinical scales consist of:
  • Functional Independence Measure scale (FIM),

  • Functional Ambulation category scale (FAC),

  • lower-leg Ashworth scale (sum of score for hip, knee and ankle) (AS),

  • Mini Balance Evaluation Systems Test (Mini-Best),

  • Motricity Index (MI),

  • Self-reported perceived effort (CR-10 Borg).

Questionnaires consist of:
  • International Knee Documentation Committee subjective knee evaluation form (IKDC),

  • Knee Outcome Survey Activity of Daily Living (KOS ADL) and health-related quality of life (SF-36).

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Participants will receive a 6-week training program in a clinical setting in add-on to the standard neuro-rehabilitation treatment. The add-on rehabilitation training will be focused on lower limb with specific activities for knee instability, and will comprise 3 weeks using the BELK orthosis knee module and 3 weeks without any orthosis.Participants will receive a 6-week training program in a clinical setting in add-on to the standard neuro-rehabilitation treatment. The add-on rehabilitation training will be focused on lower limb with specific activities for knee instability, and will comprise 3 weeks using the BELK orthosis knee module and 3 weeks without any orthosis.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting
Anticipated Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Mar 31, 2021
Anticipated Study Completion Date :
Aug 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: With knee exoskeleton

The rehabilitation training will be focused on lower limb with specific activities for knee instability, and will concern both physical training (e.g., locomotion task, balance exercise, muscle reinforcement, proprioceptive task) and occupational treatment tasks (e.g., transferring/mobility, meal preparation, house-working). Each session will be 45 minutes long. Three time per week, for three weeks. The patients allocated in this arm will perform the training wearing the BELK device.

Device: With knee exoskeleton
BELK is a wearable system that assists when and where the patient needs it intelligently through proper control of the system and optimized gait assistance techniques. Assisted-as-needed control allows to create a force field along a desired trajectory, proportionally applying torque only when patient deviates from the pre-programmed correct pattern. This force field control, by assisting only the segments that the patient need, produces a natural gait pattern, improving the rehabilitation process.

No Intervention: Without exoskeleton

The rehabilitation training will be focused on lower limb with specific activities for knee instability, and will concern both physical training (e.g., locomotion task, balance exercise, muscle reinforcement, proprioceptive task) and occupational treatment tasks (e.g., transferring/mobility, meal preparation, house-working). Each session will be 45 minutes long. Three time per week, for three weeks. The patients allocated in this arm will perform the training without any exoskeleton.

Outcome Measures

Primary Outcome Measures

  1. Change in walking velocity [Before and Immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    Walking velocity [m/s] will be calculated during walk test (10MWT). Markers positioned on the body will be tracked through a motion capture software and analyzed.

  2. Change in Gait Profile Score [Before and Immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    Gait Profile Score (GPS) is a useful index to analyze the gait performances. It is calculated starting from fifteen Gait Variable Score (GVS) which give a deeper view on the variables related to the locomotion trials.

Secondary Outcome Measures

  1. Change in 6-minute walking test (6MWT) [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    The six-minute walk test (6MWT) measures the distance, in meters, that an individual is able to walk over a total of six minutes on a hard, flat surface.

  2. Change in joint force [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    Joint forces will be calculated as the amount of pressure recorded in newtons on the force plates during walking tests.

  3. Change in Surface electromyography (sEMG) [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    Surface electromyography (sEMG) is a non-invasive procedure involving the detection, recording and interpretation of the electric activity of groups of muscles at rest (i.e., static) and during activity (i.e., dynamic). The procedure is performed using a single or an array of electrodes placed on the skin surface over the muscles to be tested. Recording can also be made using a hand-held device, which is applied to the skin surface at different sites. Electrical activity is assessed by computer analysis of the frequency spectrum, amplitude, or root-mean-square of the electrical action potential.

  4. Change in energy cost of walking [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    Energy cost of walking, expressed in ml O2/kg/m will be measured using indirect calorimetry device

  5. Change in Stair Climb Test (SCT) [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    The Stair Climb Test (SCT) measures, in seconds, the time taken by an individual to ascend and descend 10 steps (each step is 0.18 m in height).

  6. Change in Timed Up and Go test (TUG) [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    The Timed "Up and Go" Test measures, in seconds, the time taken by an individual to stand up from a standard arm chair (approximate seat height of 46 cm, arm height 65 cm), walk a distance of 3 meters (approximately 10 feet), turn, walk back to the chair, and sit down.

  7. Change in Short Form Survey Instrument (SF36) [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    Confidence levels will be calculated using the Short Form Survey Instrument (SF36). Items are scored using Likert scale and yes/no options. Scales are standardized with a scoring algorithm to obtain a score ranging from 0-100. High scores indicate better health status.

  8. Change in International Knee Documentation Committee (IKDC) Questionnaire [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. Symptoms sub scale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee. Meanwhile, the sports activity sub scale focuses on functions like going up and down the stairs, rising from a chair, squatting and jumping. The knee function sub scale asks patients one simple question: how is their knee at present versus how was their knee prior to injury? Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.

  9. Change in Knee Outcome Survey (KOS) [Before and immediately after the rehabilitation training of each arm (Initial, after 3 weeks and final)]

    The Knee Outcome Survey (KOS) is a patient-completed questionnaire that provides a percentage of disability during every day activities (activities of daily living sub scale) or sports (sports activity sub scale). The lower the percentage, the higher the disability. This is a self-report measure that is broken down into two categories (ADLs and sport activities) that rates perceived disability with 5 being "no difficulty" and 0 being "unable to perform".[1]

  10. System Usability Scale (SUS) [Immediately after the rehabilitation training of experimental arm.]

    The scores on the System Usability Scale (SUS) was measured in order to assess the usability of BELK during rehabilitation training

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age: 30 - 85

  • Sex: males and females

  • Diagnosis of Neuromuscular diseases (NMD) or central nervous system (CNS) disorder with knee instability conditioning gait

  • Functional Ambulation Categories (FAC) > 3

  • Mini Mental State Examination (MMSE) > 24

  • Ability to walk at least 10 meters alone or with maximum 1 person assistance

Exclusion Criteria:
  • Bilateral impairment of the knees

  • Knee implant

  • Lower extremity amputation

  • Severe sensorial impairment of the lower limbs

  • Legal blindness or severe visual impairment

  • Pacemakers or metal implants

  • Refusal to give informed consent

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Casa di Cura Privata del Policlinico SpA

Investigators

  • Principal Investigator: Peppino Tropea, PhD, Casa di Cura Privata del Policlinico SpA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Casa di Cura Privata del Policlinico SpA
ClinicalTrials.gov Identifier:
NCT04173975
Other Study ID Numbers:
  • BELK@CCP
First Posted:
Nov 22, 2019
Last Update Posted:
Feb 22, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 22, 2022